NCT00658593View on ClinicalTrials.gov

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 10, 2008

Primary Completion Date

May 11, 2010

Study Completion Date

January 18, 2011

Conditions
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Interventions
DRUG

capecitabine

DRUG

gemcitabine hydrochloride

PROCEDURE

quality-of-life assessment

Trial Locations (8)

T2N 4N2

Tom Baker Cancer Centre - Calgary, Calgary

T6G 1Z2

Cross Cancer Institute at University of Alberta, Edmonton

V3V 1Z2

BCCA - Fraser Valley Cancer Centre, Surrey

V5Z 4E6

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver

K1H 8L6

Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa

L2R 7C6

St. Catharines General Hospital at Niagara Health System, St. Catharines

M5G 2M9

Princess Margaret Hospital, Toronto

J4V 2H1

Hopital Charles Lemoyne, Greenfield Park

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK